Y拦截香港有限公司将其IDEXX实验室的股份减少到1 609股,价值676 000美元。 Y Intercept Hong Kong Ltd cut its IDEXX Laboratories holdings to just 1,609 shares, valued at $676,000.

Y拦截香港有限公司大大减少了它在IDEXX实验室的股份,出售了7 523个股份,现在只拥有1 609个股份,价值676 000美元。 Y Intercept Hong Kong Ltd significantly reduced its holdings in IDEXX Laboratories, selling 7,523 shares to now own only 1,609 shares, valued at $676,000. IDEXX是一家诊断和软件公司,报告Q1收入丰厚,超过分析师的预期,EPS为2.96美元,收入为9.9843亿美元。 IDEXX, a diagnostics and software company, reported strong Q1 earnings, exceeding analyst expectations with $2.96 EPS and $998.43 million in revenue. 尽管持有量减少,IDEXX的股票被评为“机动购买”,市场上限为454.5亿美元,P/E比率为52.24。 Despite the reduced holdings, IDEXX's stock is rated a "Moderate Buy" with a market cap of $45.45 billion and a P/E ratio of 52.24.